Director · Mineralys Therapeutics, Inc. · Mineralys Therapeutics, Inc. — Stock Option
Side
A
Value
—
Shares
16.6K
Price
—
Executed
Oct 19, 2026
Disclosed
Oct 20, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 19 executedOct 20, 2026 disclosed
MLYS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Peterson Kristine filed this Form 4 reporting a grant or award of MLYS on Oct 19, 2026. It became public on Oct 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Peterson Kristinecik:0001508596
Issuer
Mineralys Therapeutics, Inc.cik:0001933414
Revision history · 0
No field has changed since this record was first ingested.
